Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs. - Gremke N; Besong I; Stroh A; von Wichert L; Witt M; Elmshäuser S; Wanzel M; Fromm MF; Taudte RV; Schmatloch S; Karn T; Reinisch M; et al. (Signal transduction and targeted therapy, 2025)